47. バージャー病
[臨床試験数:7,薬物数:9(DrugBank:4),標的遺伝子数:4,標的パスウェイ数:13

Searched query = "Buerger disease", "Thromboangiitis obliterans"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03056742
(ClinicalTrials.gov)
February 20, 201723/1/2017A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers DiseaseA Single Arm, Open Label, Multicentric, Clinical Study Assessing the Efficacy and Safety of Stempeucel® (ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients With CLI Due to Buerger's DiseaseCritical Limb Ischemia Due to Buerger's DiseaseBiological: Stempeucel(R)Stempeutics Research Pvt LtdNULLWithdrawn18 Years65 YearsAll0Phase 2India
2NCT01484574
(ClinicalTrials.gov)
January 201227/11/2011A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers DiseaseA Non-randomized, Open Label, Multicentric, Dose Ranging , Phase II Study Assessing the Efficacy and Safety of Intramuscular Administration of Stempeucel - CLI™ (ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients With Critical Limb Ischemia Due to Buerger's DiseaseCritical Limb Ischemia;Buerger's DiseaseBiological: Allogeneic Mesenchymal Stem CellsStempeutics Research Pvt LtdNULLCompleted18 Years65 YearsBoth90Phase 2India